• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Avid Radiopharmaceuticals

edit

Avid develops molecular imaging agents to aid medical management of chronic human diseases. They are located in Philadelphia, PA.

Recent Milestones

edit

• 
  Avid Radiopharmaceuticals was acquired by Eli Lilly for $800M. (11/8/10)
  Posted 11/8/10 at 8:16pm via lilly.com
• 
  Avid Radiopharmaceuticals received $34.5M in Series D funding. (5/21/09)
  Posted 6/15/09 at 8:12am via avidrp.com
• 
  Avid Radiopharmaceuticals received $26M in Series C funding. (5/9/07)
  Posted 6/18/09 at 4:14pm via avidrp.com
• 
  Avid Radiopharmaceuticals received $8.9M in Series A funding. (1/5/06)
  Posted 6/18/09 at 4:17pm via avidrp.com
• 
  Avid Radiopharmaceuticals received $500k in Seed funding. (1/25/05)
  Posted 9/6/10 at 3:35am via thefreelibrary.com

Videos

Screenshots

edit

Above: Home Page
Uploaded: 6/15/09

Sources

1. Lilly to Acquire Avid Radiopharmaceuticals (newsroom.lilly.com) [edit]
2. Avid Radiopharmaceuticals Selected to Receive Seed Funding from BioAdvance (thefreelibrary.com) [edit]
3. Avid RP Closes $8.9 Million Financing to Support Development of Alzheimer's Diagnostic and Prognostic Agents (avidrp.com) [edit]
4. Avid RP Closes $26 Million Series C Financing (avidrp.com) [edit]
5. Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing (avidrp.com) [edit]